0.8757
Biofrontera Inc stock is traded at $0.8757, with a volume of 11,410.
It is down -0.50% in the last 24 hours and up +0.76% over the past month.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
See More
Previous Close:
$0.8801
Open:
$0.8801
24h Volume:
11,410
Relative Volume:
0.07
Market Cap:
$8.88M
Revenue:
$34.07M
Net Income/Loss:
$-20.13M
P/E Ratio:
-0.0678
EPS:
-12.92
Net Cash Flow:
$-24.90M
1W Performance:
-9.35%
1M Performance:
+0.76%
6M Performance:
-21.11%
1Y Performance:
-27.63%
Biofrontera Inc Stock (BFRI) Company Profile
Name
Biofrontera Inc
Sector
Phone
781-245-1325
Address
120 PRESIDENTIAL WAY,, WOBURN
Compare BFRI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
BFRI
Biofrontera Inc
|
0.8757 | 9.43M | 34.07M | -20.13M | -24.90M | -12.92 |
![]()
ZTS
Zoetis Inc
|
155.66 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.31 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.81 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.77 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
309.86 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Biofrontera Inc Stock (BFRI) Latest News
Will a bounce in Biofrontera Inc. offer an exitWeekly Trade Report & Long-Term Safe Return Strategies - Newser
Trendlines Suggest Biofrontera Inc. Equity Warrant May Bottom Out Soon2025 Stock Rankings & Stock Timing and Entry Methods - beatles.ru
Biofrontera Inc. recovery potential after sell offPortfolio Value Summary & Weekly Market Pulse Updates - Newser
Investors Hope for Bounce in Biofrontera Inc. Equity Warrant After SelloffJuly 2025 News Drivers & Weekly Breakout Watchlists - kangso.co.kr
Can Biofrontera Inc. Overcome Bearish Sentiment2025 Dividend Review & Real-Time Sentiment Analysis - sundaytimes.kr
Biofrontera Inc. Equity Warrant Stages Intraday Comeback — Trend Change2025 Retail Activity & Expert Curated Trade Ideas - beatles.ru
Can Biofrontera Inc. navigate macro headwindsQuarterly Growth Report & AI Enhanced Trade Execution Alerts - thegnnews.com
Is Biofrontera Inc. Equity Warrant stock entering bullish territoryJuly 2025 PostEarnings & Weekly Top Gainers Trade List - Newser
Relative strength of Biofrontera Inc. Equity Warrant in sector analysisWeekly Risk Report & Safe Entry Momentum Tips - Newser
What to do if you’re stuck in Biofrontera Inc. Equity WarrantWeekly Trade Recap & Reliable Breakout Stock Forecasts - Newser
Can Biofrontera Inc. recover in the next quarterEarnings Overview Report & AI Forecasted Entry and Exit Points - Newser
How institutional ownership impacts Biofrontera Inc. Equity Warrant stockJuly 2025 Final Week & Verified Technical Signals - Newser
Order flow analysis tools used on Biofrontera Inc. Equity WarrantQuarterly Profit Report & Stepwise Entry/Exit Trade Alerts - Newser
Risk adjusted return profile for Biofrontera Inc. analyzedQuarterly Trade Report & High Accuracy Swing Trade Signals - Newser
Will Biofrontera Inc. rebound enough to break evenMarket Weekly Review & Accurate Technical Buy Alerts - Newser
Using AI based signals to follow Biofrontera Inc. Equity WarrantTrade Volume Summary & Fast Entry and Exit Trade Plans - Newser
What does recent volatility data suggest for Biofrontera Inc.July 2025 Short Interest & Weekly Top Performers Watchlists - Newser
Will Biofrontera Inc. see short term momentum2025 Year in Review & Stock Timing and Entry Methods - Newser
Real time social sentiment graph for Biofrontera Inc. Equity WarrantJuly 2025 Volume & High Accuracy Swing Entry Alerts - Newser
Intraday pattern recognizer results for Biofrontera Inc. Equity Warrant2025 Institutional Moves & Breakout Confirmation Alerts - Newser
Is Biofrontera Inc. building a consolidation baseAnalyst Upgrade & Safe Investment Capital Preservation Plans - Newser
What is Biofrontera Inc. s revenue forecast2025 Market Sentiment & Weekly High Potential Alerts - newsyoung.net
Has Biofrontera Inc. formed a bullish divergenceMarket Risk Summary & Stepwise Trade Execution Plans - Newser
Statistical indicators supporting Biofrontera Inc.’s strengthMarket Risk Analysis & Free Low Drawdown Momentum Trade Ideas - Newser
What technical models suggest about Biofrontera Inc. Equity Warrant’s comebackMarket Growth Review & Fast Exit and Entry Trade Guides - Newser
Analyzing net buyer seller activity in Biofrontera Inc.Market Sentiment Review & Real-Time Volume Trigger Notifications - Newser
Smart tools for monitoring Biofrontera Inc. Equity Warrant’s price actionJuly 2025 Big Picture & Safe Entry Point Identification - Newser
Sector ETF performance correlation with Biofrontera Inc. Equity WarrantJuly 2025 Closing Moves & Momentum Based Trading Signals - Newser
Tools to monitor Biofrontera Inc. recovery probabilityTrade Risk Summary & Weekly Top Gainers Trade List - Newser
What hedge funds are buying Biofrontera Inc.Long Setup & Risk Managed Investment Strategies - sundaytimes.kr
Biofrontera Inc. (NASDAQ:BFRI) Q2 2025 Earnings Call Transcript - Insider Monkey
Why Biofrontera Inc. Equity Warrant stock attracts strong analyst attention2025 Market Outlook & Risk Managed Investment Strategies - Newser
Biofrontera signals enhanced operating leverage as U.S. independence and new patent reshape outlook - MSN
Biofrontera Inc. Reports Revenue Growth Amid Strategic Restructuring - TipRanks
Biofrontera Inc. Equity Warrant Attempts Reversal From Key SupportJuly 2025 Big Picture & Fast Moving Market Watchlists - thegnnews.com
Biofrontera Q2 Revenue Jumps 15% - AOL.com
Transcript : Biofrontera Inc., Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener
Earnings call transcript: Biofrontera Q2 2025 sees revenue growth, net loss - Investing.com
Can swing trading help recover from Biofrontera Inc. Equity Warrant lossesEarnings Miss & Breakout Confirmation Alerts - Newser
Using Ichimoku Cloud for Biofrontera Inc. technicalsPortfolio Value Report & Verified Chart Pattern Signals - Newser
Biofrontera's Q2 Revenue Jumps 15%, Despite Wider Loss Due to Increased Legal Expenses - AInvest
Biofrontera 2025 Q2 Earnings Net Loss Widens 1971.6% - AInvest
Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update - GlobeNewswire
Biofrontera Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Biofrontera Reports Strong Growth as New US Rights Deal Cuts Production Costs by Over 50% - Stock Titan
Biofrontera Inc. SEC 10-Q Report - TradingView
Can Biofrontera Inc. keep up with sector leaders2025 Sector Review & Community Consensus Trade Signals - thegnnews.com
Published on: 2025-08-13 16:20:55 - 선데이타임즈
What is Biofrontera Inc. Equity Warrant’s market positionQuarterly Trade Report & Precise Buy Zone Identification - thegnnews.com
Intraday pattern recognizer results for Biofrontera Inc.Bull Run & Free Expert Approved Momentum Trade Ideas - Newser
Using Ichimoku Cloud for Biofrontera Inc. technicals [Market Movement Recap]Safe Entry Momentum Tips - Newser
Biofrontera Inc Stock (BFRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):